Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.23.3
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation
Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:
Three Months Ended September 30, Nine Months Ended September 30,
Stock-based compensation 2023 2022 2023 2022
Cost of revenues $ 80  $ 59  $ 444  $ 154 
Sales and marketing 24  35  156  80 
General and administrative 699  760  2,818  1,827 
Research and development 35  45  244  108 
Total stock-based compensation $ 838  $ 899  $ 3,662  $ 2,169 
Schedule of Restricted Stock Unit Activity A summary of our restricted stock unit activity under the 2018 Plan for the nine months ended September 30, 2023 is set forth below:
Shares Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2022 2,957,995  $ 1.75 
Granted 6,211,386  0.53 
Released (3,215,131) 1.19 
Forfeited (578,574) 1.43 
Outstanding as of September 30, 2023 5,375,676  $ 0.62 
Schedule of Stock Option Activity
A summary of our stock option activity under the 2018 Plan and related information is as follows:
Number of Shares Weighted Average
Exercise Price		 Weighted Average
Remaining
Contractual Term
(years)		 Aggregate Intrinsic
Value
Outstanding as of December 31, 2022 87,500  $ 1.43  5.6 $ — 
Granted 75,000  0.76 
Exercised —  — 
Forfeited (37,500) 1.08 
Outstanding as of September 30, 2023 125,000  $ 1.14  5.4 $ — 
Exercisable as of September 30, 2023 106,250  $ 1.20  5.4 $ — 
A summary of our option activity under the 2009 Plan and related information is as follows:
Number of Shares Weighted Average
Exercise Price		 Weighted Average
Remaining
Contractual Term
(years)		 Aggregate Intrinsic
Value
Outstanding as of December 31, 2022 874,279  $ 0.80  4.2 $ 130 
Granted —  — 
Exercised (94,748) 0.61 
Forfeited (24,021) 1.31 
Outstanding as of September 30, 2023 755,510  $ 0.81  4.0 $ — 
Exercisable as of September 30, 2023 755,510  $ 0.81  4.0 $ —